This time at I/O, Google appeared to get the upper hand, vibe-wise, with a flurry of new models and features, a vision of a ...

Devindra has been writing about the way technology intersects with our lives for nearly 20 years. He started the Amherst ...

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

Not unlike Regeneron's acquisition of 23andMe, Predictive Oncology's AI-driven breakthroughs reflect a broader transformation ...

Huang’s comments came as the truce between the U.S. and China over tariffs and semiconductors continues to be delicate.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

Salesforce Inc. will offer its Slack application to the federal government at a discounted rate, the latest software company ...

The latest warnings from JPMorgan’s Jamie Dimon on geopolitical risks and tariffs have become par for the course.While he ...

Uh-oh. We’re in conference hell, one of those periods of the year when tech companies try to seize control of the news cycle with a seemingly never-ending stream of product announcements (many ...